{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:20:47Z","timestamp":1759332047137},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.ophtha.2007.04.059","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T07:15:09Z","timestamp":1187853309000},"page":"633-638.e4","source":"Crossref","is-referenced-by-count":13,"title":["Health Care Charges for Patients with Ocular Hypertension or Primary Open-angle Glaucoma"],"prefix":"10.1016","volume":"115","author":[{"given":"Louis R.","family":"Pasquale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Dolgitser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Wentzloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee S.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina H.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Walt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.ophtha.2007.04.059_bib1","first-page":"335","article-title":"The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975","volume":"24","author":"Leibowitz","year":"1980","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people worldwide with glaucoma in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib4","first-page":"1937","article-title":"Open-angle glaucoma","volume":"67","author":"Distelhorst","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ophtha.2007.04.059_bib5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2005.067355","article-title":"Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe","volume":"89","author":"Traverso","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajo.2005.07.044","article-title":"Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease","volume":"141","author":"Mills","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ijg.0000212250.95078.6f","article-title":"Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study","volume":"15","author":"Gieser","year":"2006","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2007.04.059_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ajo.2006.01.019","article-title":"Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study","volume":"141","author":"Kymes","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00061198-200004000-00004","article-title":"Cost analysis of glaucoma medications","volume":"9","author":"Vold","year":"2000","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2007.04.059_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9394(03)00102-8","article-title":"Medical therapy cost considerations for glaucoma","volume":"136","author":"Fiscella","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib11","first-page":"614","article-title":"A cost analysis of the prostaglandin analogs","volume":"73","author":"Mick","year":"2002","journal-title":"Optometry"},{"key":"10.1016\/j.ophtha.2007.04.059_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/jop.2004.20.383","article-title":"A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension","volume":"20","author":"Day","year":"2004","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2007.04.059_bib13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1742-1241.2005.00616.x","article-title":"The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients\u2014a European perspective","volume":"59","author":"Tuil","year":"2005","journal-title":"Int J Clin Pract"},{"issue":"suppl","key":"10.1016\/j.ophtha.2007.04.059_bib14","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ajo.2005.06.030","article-title":"Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications","volume":"141","author":"Noecker","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00002512-200623010-00004","article-title":"Estimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertension","volume":"23","author":"Fiscella","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ophtha.2007.04.059_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1395-3907.2004.00295.x","article-title":"How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications","volume":"82","author":"De Natale","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2007.04.059_bib17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archopht.123.10.1351","article-title":"Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma","volume":"123","author":"Medeiros","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.04.059_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00061198-200408000-00014","article-title":"A risk calculator to determine the probability of glaucoma","volume":"13","author":"Mansberger","year":"2004","journal-title":"J Glaucoma"},{"year":"1999","series-title":"ICD-9-CM International Classification of Diseases, 9th Revision: Clinical Modification","key":"10.1016\/j.ophtha.2007.04.059_bib20"},{"key":"10.1016\/j.ophtha.2007.04.059_bib22","first-page":"122","article-title":"Episode treatment groups: an illness classification and episode building system\u2014part II","volume":"9","author":"Dang","year":"1996","journal-title":"Med Interface"},{"key":"10.1016\/j.ophtha.2007.04.059_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0420.2005.00560.x","article-title":"A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden","volume":"84","author":"Lindblom","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2007.04.059_bib25","first-page":"147","article-title":"Gender differences in the utilization of health care services","volume":"49","author":"Bertakis","year":"2000","journal-title":"J Fam Pract"},{"key":"10.1016\/j.ophtha.2007.04.059_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00005650-200106000-00008","article-title":"Medical care expenditures for hypertension, its complications, and its comorbidities","volume":"39","author":"Hodgson","year":"2001","journal-title":"Med Care"},{"issue":"suppl","key":"10.1016\/j.ophtha.2007.04.059_bib27","first-page":"S90","article-title":"The cost of treating the 10 most prevalent diseases in men 50 years of age or older","volume":"12","author":"Fenter","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ophtha.2007.04.059_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00017","article-title":"Cost-effectiveness of detecting and treating diabetic retinopathy","volume":"124","author":"Javitt","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2007.04.059_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00002512-200522040-00004","article-title":"The economic burden of glaucoma and ocular hypertension: implications for patient management: a review","volume":"22","author":"Rouland","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ophtha.2007.04.059_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00061198-200106000-00007","article-title":"Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands","volume":"10","author":"Oostenbrink","year":"2001","journal-title":"J Glaucoma"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007005829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007005829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T19:55:59Z","timestamp":1546631759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642007005829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0161642007005829"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.04.059","relation":{},"ISSN":["0161-6420"],"issn-type":[{"type":"print","value":"0161-6420"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}